Oftentimes there is no correlation as their biggest CNS drug isn’t Adderall. However, Adderall was specifically called out in favorable light in both volume and margin profile. That is good news to Elite.
Lannett has been reporting overall CNS revenue declines for a while now.
And EVERY time Elite continues to set new quarterly revenue records.
Why? Because Lannett's CNS sales include Concerta which is struggling.
So the pattern has been the LOWER Lannett's CNS revenues, the HIGHER Elite's revenues.
You also have to take into account Elite has like FREAKING 10 other drugs they sell which have also been selling better.
Not to put a damper on the Adderall report from LCI, sales of CNS drugs for Lannett were actually down $2M from the comparative quarter in 2021. Hopefully the shortfall was from central nervous drugs other than the Adderall they sell. Hard to catch a friggin break here it seems.